GlaxoSmithKline
GSK
#288
Rank
C$98.85 B
Marketcap
$48.30
Share price
-0.64%
Change (1 day)
0.48%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $4.72

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $4.98. In 2022 the company made an earnings per share (EPS) of $12.07 an increase over its 2021 EPS that were of $4.26.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.72-60.86%
2022$12.07183.39%
2021$4.26-17.83%
2020$5.1821.82%
2019$4.2523.91%
2018$3.43141.48%
2017$1.4264.6%
2016$0.86-90.64%
2015$9.23178.14%
2014$3.32-48.16%
2013$6.4022.63%
2012$5.22-11.32%
2011$5.88230.25%
2010$1.78-70.98%
2009$6.146.76%
2008$5.75-15.14%
2007$6.787.82%
2006$6.2919.61%
2005$5.2518.56%
2004$4.430.36%
2003$4.4250.39%
2002$2.9431.13%
2001$2.24-25.43%
2000$3.0031.58%
1999$2.281.05%
1998$2.26-0.98%
1997$2.28-10.07%
1996$2.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.82-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.65-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.59-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.32 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.52-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$2.85-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.24-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA